Comparison of Two Different Treatment Strategies in Patients With Major Depressive Disorder Not Exhibiting Improvement on Escitalopram Treatment: Early vs. Delayed Intervention Strategy.

Trial Profile

Comparison of Two Different Treatment Strategies in Patients With Major Depressive Disorder Not Exhibiting Improvement on Escitalopram Treatment: Early vs. Delayed Intervention Strategy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 14 Sep 2013

At a glance

  • Drugs Duloxetine (Primary) ; Escitalopram
  • Indications Major depressive disorder
  • Focus Therapeutic Use
  • Acronyms HMGD
  • Sponsors Eli Lilly
  • Most Recent Events

    • 04 Jul 2012 Planned number of patients changed from 580 to 1160 as reported by EudraCT.
    • 05 Dec 2011 Results presented at the 11th International Forum on Mood and Anxiety Disorders.
    • 12 Mar 2010 Actual number of patients (522) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top